Contract Development of Finished Drug Products

In the field of Contract Development of FDFs, Midas offers its expertise and experience in particular for „difficult to make“ and „difficult to get“ products!

Added Value by Experience 

Understanding us as a partner, we support you already in the ideation phase and aim to provide you with the best tailormade solution. Midas own product portfolio is the best proof that we have the required experience to turn ideas into products. 

You like to contact us? You have any questions?

Do not hesitate to get in touch with us. We are looking forward to your enquiry.

Contract Development

Learn more about our differentiated approach to executing Contract Development of Finished Drug Products: 

  • Product & Market Definition

    Product Definition

    • Which kind of dosage form is recommended?
    • Which dosages are suitable?
    • Which indication is preferable?

    Market Definition

    • Are there markets you are not aware of?
    • Are there markets Midas may enable you to access?
    • Are there markets you are not interested in, but may also benefit you in addition via the Midas Out-Licensing Network?
  • Evaluation & Feasibility
    • Our Business Development will be supported by dedicated internal experts from
      • Clinical & Medical Affairs
      • Regulatory Affairs
      • Finished Product Development
      • Intellectual Property (Patent Attorneys)
    • Our technical experts
      • will challenge the product idea "down to the last detail"
      • will interact intensively and cooperate
      • will advise the BD-team when meeting with you
    • The entire Midas team aims to provide you with the best tailor-made solution at the end for
      • your desired product (formerly known as „difficult to make“)
      • your desired product (formerly known as „difficult to get“)
  • Tailor-made solution
    • The outcome of the evaluation and feasibility, what the entire Midas team is aiming for, is a tailor-made solution for your product idea.
  • Reducing complexity
    • Midas sees itself as the CDMO dedicated to your product

    • Midas supports you beyond the Contract Development    
      • Sublicensing your product in your name
      • Supplying you and your licensees with the product

Your Contact

Andreas Kahm

Andreas Kahm

Business Development
Senior Manager

Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Germany

Business Development & Licensing Support

With decades of experience in pharmaceutical licensing we support you to make your projects a success.
 

Share this page